PHILADELPHIA, PA—For patients with obesity who are undergoing electrical cardioversion for atrial fibrillation (AF), delivering twice the energy with a simultaneous dual approach is a better option ...
ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
All the selected patients for the study were under antiarrhythmic drug treatment (amiodarone 200 mg/day) before the procedure and during the whole follow-up after ECV. Moreover, all of them were also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results